ISPC
ISPC
NASDAQ · Health Care

Ispecimen Inc

$0.66
-0.04 (-5.43%)
As of Nov 14, 2:53 AM ET ·
Financial Highlights (FY 2026)
Revenue
42.22M
Net Income
-229,565,416
Gross Margin
1.2%
Profit Margin
-543.7%
Rev Growth
-43.0%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 1.2% 1.2% 46.6% 46.6%
Operating Margin -465.4% -418.9% 15.9% 13.1%
Profit Margin -543.7% -516.5% 10.7% 14.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 42.22M 74.04M 890.1K 703.7K
Gross Profit 527.8K 925.5K 415.1K 328.2K
Operating Income -196,522,007 -310,134,677 141.2K 92.5K
Net Income -229,565,416 -362,281,035 95.2K 101.7K
Gross Margin 1.2% 1.2% 46.6% 46.6%
Operating Margin -465.4% -418.9% 15.9% 13.1%
Profit Margin -543.7% -516.5% 10.7% 14.5%
Rev Growth -43.0% -43.0% +8.3% +9.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 1.46M 1.43M
Total Equity — — 1.24M 1.20M
D/E Ratio — — 1.18 1.19
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -195,022,203 -324,866,022 175.3K 162.6K
Free Cash Flow — — 124.9K 90.2K